PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.26%
Revenue growth at 50-75% of ADI's 10.72%. Martin Whitman would worry about competitiveness or product relevance.
5.32%
Gross profit growth under 50% of ADI's 38.70%. Michael Burry would be concerned about a severe competitive disadvantage.
5.90%
EBIT growth below 50% of ADI's 151.72%. Michael Burry would suspect deeper competitive or cost structure issues.
6.24%
Operating income growth under 50% of ADI's 151.72%. Michael Burry would be concerned about deeper cost or sales issues.
4.09%
Net income growth under 50% of ADI's 179.66%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.20%
EPS growth under 50% of ADI's 181.13%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.81%
Diluted EPS growth under 50% of ADI's 181.13%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.33%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.43%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.04%
Dividend growth under 50% of ADI's 10.24%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-17.54%
Negative OCF growth while ADI is at 42.67%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-31.16%
Negative FCF growth while ADI is at 48.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
93.65%
10Y revenue/share CAGR at 50-75% of ADI's 151.26%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
52.48%
5Y revenue/share CAGR at 75-90% of ADI's 69.16%. Bill Ackman would encourage strategies to match competitor’s pace.
44.72%
3Y revenue/share CAGR 1.25-1.5x ADI's 37.62%. Bruce Berkowitz might see better product or regional expansions than the competitor.
224.56%
10Y OCF/share CAGR in line with ADI's 208.59%. Walter Schloss would see both as similarly efficient over the decade.
108.31%
5Y OCF/share CAGR above 1.5x ADI's 53.09%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
0.26%
3Y OCF/share CAGR under 50% of ADI's 28.73%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
536.51%
Net income/share CAGR above 1.5x ADI's 174.42% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
134.40%
Below 50% of ADI's 446.99%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
78.80%
3Y net income/share CAGR above 1.5x ADI's 50.48%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
56.50%
Below 50% of ADI's 439.44%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.19%
Below 50% of ADI's 143.22%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
69.13%
3Y equity/share CAGR at 50-75% of ADI's 123.34%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
573.58%
10Y dividend/share CAGR above 1.5x ADI's 153.78%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
129.97%
5Y dividend/share CAGR above 1.5x ADI's 86.45%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
49.53%
3Y dividend/share CAGR 1.25-1.5x ADI's 40.86%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
22.01%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
6.75%
Inventory growth well above ADI's 10.56%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.86%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
-6.43%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
5.88%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
No Data
No Data available this quarter, please select a different quarter.